Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis.
about
Megakaryocyte pathology and bone marrow fibrosis: the lysyl oxidase connectionBlast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factorsSNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study.Chromosome 5q deletion is extremely rare in patients with myelofibrosisThe natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms.Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs).Therapeutic potential of Janus-activated kinase-2 inhibitors for the management of myelofibrosisAllogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors.Advances in molecular diagnostics of myeloproliferative disorders.The evolution and clinical relevance of prognostic classification systems in myelofibrosis.Polyploidy in myelofibrosis: analysis by cytogenetic and SNP array indicates association with advancing diseaseA Rare Presentation of Extramedullary Hematopoiesis in Post-polycythemic Myelofibrosis.The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis.Proposed criteria for response assessment in patients treated in clinical trials for myeloproliferative neoplasms in blast phase (MPN-BP): formal recommendations from the post-myeloproliferative neoplasm acute myeloid leukemia consortiumCharacteristics and clinical significance of cytogenetic abnormalities in polycythemia vera.SOHO State-of-the-Art Update and Next Questions: MPN.Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene.
P2860
Q24607513-6051DBE1-0AAB-4103-B6B8-87D52EB7A322Q26777265-EFD25F14-9AE9-429E-AB47-7CC0A761E7DDQ33306707-0D4E178D-A9B2-4FDB-AD68-025962FE094DQ33387514-5623868A-E2D3-43F6-9981-1E9477B5A5E5Q34037065-A55430E3-A52F-4373-B6CF-9A2F46466408Q35535523-165CB8E2-0C6D-482B-BFC2-01CE3C92E312Q36843673-32753D52-BB1B-4D5E-A882-DFB2A43C8A8EQ37255020-96062ACF-0529-4456-A4A0-0AE04E16F463Q37705695-1138F9B8-F94E-4B89-928C-7398AA02BA72Q38018908-216C365F-16E8-49D7-94BE-A94DB19757EBQ38089228-39891912-3D4C-4520-8B87-9F792F1CA9D8Q38683077-1018FF79-84FF-4508-9941-CF5288A4D96BQ41900286-B425395C-4C0C-417D-9472-18F2B7A42DD3Q42065360-F8B5F8CE-55D8-493E-B3CF-03690D671EB9Q42385052-87BC565D-4C95-4F86-AB81-A9AC26B80C5FQ42753989-4A64114E-660E-4D34-9C5D-0F6590C12D82Q45332610-D144650F-47D2-4438-A81F-F602630B78A7Q49580473-9412AD03-BD3A-4F6E-B0E0-2BA0068E32A4Q50481525-0577EEBF-C5BE-495A-B515-A27ABE99AB01
P2860
Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Presence of unfavorable cytoge ...... al in secondary myelofibrosis.
@ast
Presence of unfavorable cytoge ...... al in secondary myelofibrosis.
@en
type
label
Presence of unfavorable cytoge ...... al in secondary myelofibrosis.
@ast
Presence of unfavorable cytoge ...... al in secondary myelofibrosis.
@en
prefLabel
Presence of unfavorable cytoge ...... al in secondary myelofibrosis.
@ast
Presence of unfavorable cytoge ...... al in secondary myelofibrosis.
@en
P2093
P356
P1433
P1476
Presence of unfavorable cytoge ...... al in secondary myelofibrosis.
@en
P2093
Chin-Yang Li
Gordon W Dewald
Ruben A Mesa
Susan M Schwager
P304
P356
10.1002/CNCR.21868
P407
P577
2006-05-01T00:00:00Z